Kukjeon Pharmaceutical Co., Ltd. (307750) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kukjeon Pharmaceutical Co., Ltd. (307750:KRX), powered by AI.

Current Price
₩2,555
P/E Ratio
-32.1
Market Cap
137.9B
Sector
Healthcare
What is the Kukjeon Pharmaceutical Co., Ltd. stock price forecast?

Kukjeon Pharmaceutical Co., Ltd. is currently trading at ₩2,555. View real-time AI analysis on Alpha Lenz.

What is Kukjeon Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Kukjeon Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Kukjeon Pharmaceutical Co., Ltd.'s P/E ratio?

Kukjeon Pharmaceutical Co., Ltd.'s P/E ratio is -32.1.

Kukjeon Pharmaceutical Co., Ltd.

KRX · 307750
₩2,555+45(+1.79%)Market closedKRX regular session 09:00–15:30 KST
Ask about Kukjeon Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Kukjeon Pharmaceutical Co., Ltd. trades at a P/E of -32.1 (undervalued) with modest ROE of -4.4%.

Ask for details

Company Overview

Kukjeon Pharmaceutical Co., Ltd. is a prominent player in the biotechnology and pharmaceutical industry, primarily focusing on the research, development, and manufacturing of innovative medical products. The company's core mission is to enhance health and well-being through cutting-edge medical solutions. It specializes in a wide range of pharmaceutical products, including patented drugs, generics, and over-the-counter medications that cater to various therapeutic areas such as cardiovascular health, oncology, and infectious diseases. Kukjeon Pharmaceutical places a strong emphasis on quality, safety, and efficacy, adhering to stringent regulatory standards. Its operations significantly impact the healthcare sector, supporting medical advancements and addressing unmet medical needs. As it expands its portfolio and global reach, Kukjeon Pharmaceutical Co., Ltd. plays a crucial role in the advancement of pharmaceutical sciences and contributes to improving patient outcomes across diverse markets.

CEO홍종호
SectorHealthcare
IndustryDrug Manufacturers - General
Employees172

Company Statistics

FY 2025

Profile

₩137,934,965,840Market Cap
₩131,039,398,700Revenue
53.99MShares Out
172Employees

Margins

14.09%Gross
1.50%EBITDA
-1.97%Operating
-4.32%Pre-Tax
-3.68%Net

Valuation

-32.09P/E
1.43P/B
1.05EV/Sales
89.35EV/EBITDA
18.58P/FCF

Growth (CAGR)

8.11%Rev 3Yr
10.20%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-2.46%ROA
-4.44%ROE
-0.26%ROIC

Financial Health

₩7,693,875,700Cash & Cash Equivalents
₩75,640,769,040Net Debt
86.92%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Kukjeon Pharmaceutical Co., Ltd. (ticker: 307750) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - General). It has approximately 172 employees. Market cap is $137.9B.

The current price is ₩2,555 with a P/E ratio of -32.09x and P/B of 1.43x.

ROE is -4.44% and operating margin is -1.97%. Annual revenue is $131.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Kukjeon Pharmaceutical Co., Ltd. (307750) Stock Forecast 2026 ₩2,555 — Price, Financials & Analyst Targets | Alpha Lenz